Fraudulent Botox products may exist. Always check the translucent silver Allergan seal is intact on the Botox carton labeling. or the vial label contains a holographic film with the name Allergan with rainbow-colored horizontal lines on it, and there is a U.S. license number 1145 on the vial label and carton labeling. When used to treat bladder dysfunction, patients should not have a post-void residual (PVR) urine volume of more than 200mL if they are not self-catheterizing, nor a urinary tract infection (UTI) at the time of the appointment.
The injection needle should be filled (primed) with approximately 1 mL of reconstituted BOTOX prior to the start of injections (depending on the needle length) to remove any air.
Volume of reconstituted BOTOX and Diluent* (mL) to draw into dosing syringe to achieve a final volume of 10 mL
Getting "too much" Botox often means exceeding the amount needed for this subtle result, leading to undesirable cosmetic outcomes or potentially increasing side effect risks. It is important to be treated by a qualified, experienced medical professional (like a board-certified dermatologist, plastic surgeon, or properly trained nurse practitioner/physician assistant under supervision) who understands anatomy and appropriate dosing.
The safe and effective use of BOTOX depends upon proper storage of the product, selection of the correct dose, and proper reconstitution and administration techniques. An understanding of standard electromyographic techniques is also required for treatment of strabismus, upper or lower limb spasticity, and may be useful for the treatment of cervical dystonia.
Dosing in initial and sequential treatment sessions should be tailored to the individual patient based on the patient’s head and neck position, localization of pain, muscle hypertrophy, patient response, and adverse event history.
Check out these common questions for more info about Radiesse Injectables and what your patients can expect from treatment.
Injection without surgical exposure or electromyographic guidance should not be attempted. Physicians should be familiar with electromyographic technique.
Patients should be considered for reinjection when the clinical effect of the previous injection has diminished (median time until patients qualified for the second treatment of BOTOX in double-blind, placebo-controlled clinical studies was 169 days [~24 weeks]), but pelo sooner than 12 weeks from the prior bladder injection.
You should not use RADIESSE® or RADIESSE® (+) if you have an allergy to any component of the product, if you have a history of severe allergies, if you have a bleeding disorder, or if you are pregnant or breastfeeding. You should not use RADIESSE® (+) if you have an allergy to lidocaine or medicines like it.
Please see the Patient Information Guide available at for list of these events. Tell your health care provider about any side effects that bother you or do not go away.
Must be administered by a licensed provider and reconstituted exactly as directed by the manufacturer.
Tell radiesse your health care provider if you have any diseases, injuries or disabilities of the hand, if you have a history forming large, raised scars or if you have had any other skin treatments such as skin peels.
The initial listed doses of the reconstituted BOTOX typically create paralysis of the injected muscles beginning one to two days after injection and increasing in intensity during the first week. The paralysis lasts for 2-6 weeks and gradually resolves over a similar time period.